These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

221 related articles for article (PubMed ID: 2088183)

  • 21. In vitro activity of oritavancin and comparator agents against staphylococci, streptococci and enterococci from clinical infections in Europe and North America, 2011-2014.
    Biedenbach DJ; Arhin FF; Moeck G; Lynch TF; Sahm DF
    Int J Antimicrob Agents; 2015 Dec; 46(6):674-81. PubMed ID: 26541881
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Proceedings: Epidemiologic and genetic studies of antibiotic resistance in enterococci].
    Marder HP; Kayser FH
    Pathol Microbiol (Basel); 1974; 41(3-4):131-2. PubMed ID: 4444823
    [No Abstract]   [Full Text] [Related]  

  • 23. Cloning and heterospecific expression of the resistance determinant vanA encoding high-level resistance to glycopeptides in Enterococcus faecium BM4147.
    Brisson-Noël A; Dutka-Malen S; Molinas C; Leclercq R; Courvalin P
    Antimicrob Agents Chemother; 1990 May; 34(5):924-7. PubMed ID: 2360831
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Glycopeptides in lung and bone diseases in children].
    Gendrel D
    Presse Med; 1999 Apr; 28(13):718-9. PubMed ID: 10228486
    [No Abstract]   [Full Text] [Related]  

  • 25. Transferable vancomycin and teicoplanin resistance in Enterococcus faecium.
    Leclercq R; Derlot E; Weber M; Duval J; Courvalin P
    Antimicrob Agents Chemother; 1989 Jan; 33(1):10-5. PubMed ID: 2523687
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Antibiotic sensitivity of enterococci isolated from various water supplies].
    Bălteanu E; Finichiu M; Freund S
    Rev Med Chir Soc Med Nat Iasi; 1967; 71(3):645-50. PubMed ID: 6065596
    [No Abstract]   [Full Text] [Related]  

  • 27. [Molecular and epidemiologic aspects of the resistance to antibiotics: example of glycopeptides on enterococci].
    Courvalin P
    C R Seances Soc Biol Fil; 1996; 190(4):467-9. PubMed ID: 8952897
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Prevalence of high-level resistance to aminoglycosides in clinical isolates of enterococci.
    Moellering RC; Wennersten C; Medrek T; Weinberg AN
    Antimicrob Agents Chemother (Bethesda); 1970; 10():335-40. PubMed ID: 5521352
    [No Abstract]   [Full Text] [Related]  

  • 29. Antibiotic resistance among enterococci: current problems and management strategies.
    Murray BE
    Curr Clin Top Infect Dis; 1991; 11():94-117. PubMed ID: 1907832
    [No Abstract]   [Full Text] [Related]  

  • 30. In vitro activity of six antibiotics against multiresistant staphylococci and other gram-positive cocci.
    Dixson S; Brumfitt W; Hamilton-Miller JM
    Eur J Clin Microbiol; 1985 Feb; 4(1):19-23. PubMed ID: 3157567
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Staphylococci and enterococci resistant to glycopeptides: the challenge of the year 2000?].
    Mainardi JL
    Pathol Biol (Paris); 1998 May; 46(5):289-90. PubMed ID: 9769886
    [No Abstract]   [Full Text] [Related]  

  • 32. [Susceptibility to betalactam antibiotics, glycopeptides and aminoglycosides in commensal strains of erythromycin-resistant alpha-hemolytic streptococci and Gemella spp].
    Cerdá-Zolezzi P; Goñi-Cepero P; Millán-Laplana L; Rubio-Calvo C; Durán E; Oca M; Gómez-Lus R
    Enferm Infecc Microbiol Clin; 2008 Jan; 26(1):4-9. PubMed ID: 18208759
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Resistance of enterococci to antibiotic combinations.
    Chen HY
    J Antimicrob Chemother; 1986 Jul; 18(1):1-4. PubMed ID: 3093442
    [No Abstract]   [Full Text] [Related]  

  • 34. In vitro evaluation of teicoplanin and other antimicrobials against streptococci group D bacteria.
    Breyer S; Georgopoulos A; Graninger W
    Drugs Exp Clin Res; 1987; 13(8):479-81. PubMed ID: 2962843
    [TBL] [Abstract][Full Text] [Related]  

  • 35. In vitro interactions between teicoplanin and other antibiotics against enterococci and staphylococci.
    Debbia E; Pesce A; Schito GC
    J Hosp Infect; 1986 Mar; 7 Suppl A():73-7. PubMed ID: 2871100
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Mechanisms and implications of glycopeptide resistance in enterococci.
    Derlot E; Courvalin P
    Am J Med; 1991 Sep; 91(3B):82S-85S. PubMed ID: 1656750
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Activity of teicoplanin compared with vancomycin alone, and combined with gentamicin, against penicillin tolerant viridans streptococci and enterococci causing endocarditis.
    Shanson DC; Tadayon M
    J Hosp Infect; 1986 Mar; 7 Suppl A():65-72. PubMed ID: 2871099
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Microbiological properties of teicoplanin.
    Greenwood D
    J Antimicrob Chemother; 1988 Jan; 21 Suppl A():1-13. PubMed ID: 2965119
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Detection of glycopeptide resistance in clinical isolates of gram-positive bacteria.
    Harding I; Lockett A; Brown E
    J Antimicrob Chemother; 1992 Jul; 30(1):105-8. PubMed ID: 1429329
    [No Abstract]   [Full Text] [Related]  

  • 40. In vitro activity of 43 antimicrobial agents tested against ampicillin-resistant enterococci and gram-positive species resistant to vancomycin.
    Yamane N; Jones RN
    Diagn Microbiol Infect Dis; 1991; 14(4):337-45. PubMed ID: 1889183
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.